Health Policy in Singapore

Health Policy in Singapore


Overview

For over three years, Duke-Margolis has collaborated with Duke-NUS and key organizations in the country to accelerate and support Singapore’s ongoing health system transformation to achieve better population health. Partners have included Centre of Regulatory Excellence (CoRE) at Duke-NUS, Ministry of Health (MOH), MOH Office for Healthcare Transformation (MOHT).

While Singapore’s world-class health system is performing very well by many measures – including per-capita costs and health outcomes – the Ministry of Health is implementing the “3 Beyonds" strategy: Beyond hospital to community; Beyond quality to value; and Beyond healthcare to health to adapt its system to reflect medical progress and serve its aging population, which will double by 2030 and account for a quarter of the country’s citizens. Singapore is addressing key policy issues including delaying the onset of chronic diseases, increasing home-based care for chronic disease management and coordinating care for people with high-cost conditions. Many of these issues require a multi-dimensional policy, care delivery and payment solutions spanning developing a funding stream that follows the person, covering medical and non-medical care across the continuum of care, to increase flexibility and promote innovation, creating and supporting an accountable entity to integrate capabilities and support an integrated care pathway, and creating a patient-centered models to manage of chronic diseases.

Impact

Increased understanding of value-based care and exchange of best practices.

Activities

The team has organized roundtables with all three health clusters in Singapore – National University Health System (NUHS), SingHealth and National Healthcare Group (NHG) – and multiple public symposia, including co-organizing a conference with the Ministry of Health that facilitated dialogue on value-based care and reached over 500 health leaders. In addition, the team has built relationships with over 50 public and private sector actors. 

Funder: Duke-NUS

See specific projects below

value-driven outcomes

Value-Driven Outcomes in Singapore

The Ministry of Health (MOH) and three health clusters in Singapore have been leading healthcare system transformation in Singapore to implement the “3 Beyonds" strategy: Beyond hospital to community; Beyond quality to value; and Beyond healthcare to health. Since 2017, Duke-Margolis has engaged with stakeholders in Singapore to advance value-driven outcomes, including co-developing the first conference on VDO in the country with MOH

biomedical innovation

Biomedical Innovation and Regulatory Policy in Singapore

Duke-Margolis has established connections and explored potential joint research projects with Singapore’s Ministry of Health (MoH) and Health Sciences Authority (HSA, Singapore’s FDA equivalent). We have held seminars and roundtables on RWD and RWE in collaboration with the Duke-National University of Singapore’s (Duke-NUS) School of Medicine and Centre for Regulatory Excellence (CoRE). 

Duke-Margolis Team

Andrea Thoumi

Andrea Thoumi, MPP, MSc

Health Equity Policy Fellow
Senior Team Member
Anti-Racism and Equity Committee Member
Core Faculty Member
Adjunct Assistant Professor
2020 Intern Mentor

Janet Prvu Bettger

Janet Prvu Bettger, ScD, FAHA

Director of Undergraduate Education and Research Initiatives, Margolis Center
Margolis Core Faculty
Associate Professor of Orthopaedic Surgery
2020 Intern Mentor
Anti-Racism and Equity Committee Member

morgan romine

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty

krishna

Krishna Udayakumar, MD, MBA

Director of Post-Graduate Education Initiatives, Margolis Center
Associate Professor of Global Health and Medicine
Margolis Executive Core Faculty
2020 Intern Mentor